HomeAI · summaries
Storia in 14 fonti
Eli Lilly files lawsuits against six companies for allegedly selling retatrutide
Eli Lilly and Co. has filed lawsuits against six companies that it claims are selling counterfeit, unapproved versions of its investigational diabetes and obesity drug, retatrutide, according to a press release. Eli Lilly stated in the release it chose to file lawsuits against six entities selling illegal versions of the glucose-dependent insulinotropic polypeptide (GIP)/GLP-1/glucagon triple
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide
Ahead of an approval filing, the drugmaker is amping up a fight against sellers who claim to offer versions of its highly anticipated “triple-G” weight loss medicine.
- ·
thehindubusinessline.com
Eli Lilly escalates fight against black market weight-loss medicines
The drug company said Wednesday that it planned to file lawsuits against US businesses that sell retatrutide products illegally, and it’s asking regulators to do more to rein in…
